Systech International Announces Ara Ohanian as CEO
The company positions for robust growth

PRINCETON, New Jersey – March 20, 2018 – Systech International, global leader in serialization, track-and-trace and brand protection, today announces Ara Ohanian as its new chief executive officer. Mr. Ohanian succeeds Robert DeJean with his full support while retiring from the day-to-day after 32 years of leadership.

“We’re thrilled to have Ara Ohanian join Systech as our new CEO”, stated Michael Dubilier, Chairman of the Systech Board of Directors. “Ara’s previous success leading complex regulatory compliance ERP operations, coupled with his track record scaling enterprise SaaS hyper-growth are the perfect complement for leading Systech”.

“I’m honored to join the Systech team and serve its impressive roster of blue chip clients. With decades of success as the pioneer of serialization and leader in product verification, Systech is uniquely positioned to extend its robust, fail-safe solution to defend global brands against the escalating threat of product counterfeiting.”

Mr. Ohanian most recently led the explosive growth of Unite US’ care coordination platform bridging healthcare and social services. Previously, he served as SVP & GM Infor (www.infor.com), the world’s third largest enterprise software company. At Infor, he led Infor’s statutory compliance solution supporting Infor ERPs across 91 global markets. Prior to Infor, Mr. Ohanian was founder and CEO Of Certpoint Systems, a Learning Management System leader, which was acquired by Infor in April 2013.

Robert DeJean, founder and director of Systech remarked “I have been fortunate to work with a very talented and passionate team in building Systech into a global leader.  I have great confidence that Ara is the right leader to take Systech’s technology leadership position to a global marketplace leadership.”

WEBINAR | June 6th at 10am EST/4pm CET
IDC_Logo

Pharma supply chain insights to action

with IDC Analysts

Exclusive data-driven session on “Solving the Critical Pharmaceutical Supply Chain Challenges” with the latest research findings on industry trends and innovative technologies to address market needs.